Help us: Donate
Follow us on:
×

Menu

Back

Month: July 2018

The July edition of the Journal Club saw us taking a look at a recent paper that casts doubt and concern over the use of CRISPR/Cas9 for gene editing. The researchers raised concerns that using it may result in genomic damage, something that was missed by previous researchers working with this powerful gene editing tool....
The topic of life extension is much more debated these days than before. As a result, more people who are not in the field talk about it, and they don't always do so in praising terms. Articles written by outsiders tend to be conservative at best and fear-mongering at worst, mainly focusing on the potential...
Today, we have an interview with Dr. João Pedro de Magalhães, the biogerontologist who created and runs senescence.info. How do you think we age; are we programmed to die, do we wear out, or is the truth a mixture of both? I don't think we wear out. Humans and complex animals are made of cells...
Today we have an interview with Dr. Aubrey de Grey from the SENS Research Foundation. This interview conducted by Yuri Deigin, CEO at Youthereum Genetics, was originally published in Russian language and he has kindly translated it into English so our audience can enjoy it too. Yuri: Aubrey, thank you very much for agreeing to this...
Two studies by researchers at the University of Birmingham have shown that delivering drugs against the wet form of age-related macular degeneration (AMD) in the form of eyedrops might soon be possible in humans [1, 2]. What is age-related macular degeneration? AMD is a pathology of the retina, which is a light-sensitive tissue located in...
Today, we are pleased to announce that the results are in from a human trial that targets the aging immune system and that an immune system-boosting drug appears to be effective. Targeting TORC1 to boost the immune system As we age, the immune system becomes increasingly poor and unable to detect and fight infections. This...